temoporfin has been researched along with Carcinoma, Basal Cell in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hamdoon, Z; Hopper, C; Jerjes, W | 1 |
| Horlings, RK; Terra, JB; Witjes, MJ | 1 |
| Albrecht, V; Betz, CS; Hopper, C; Nifantiev, NE; Rauschning, W; Riabov, MV; Stranadko, EP | 1 |
| Albrecht, V; Betz, CS; Hopper, C; Nifantiev, NE; Rauschning, W; Riabov, MV; Stranadko, EP; Volgin, VN | 1 |
| Baas, P; Haller, U; Klein, SD; Walt, H; Zimmermann, A | 1 |
| Baas, P; Out, R; Ruevekamp, M; Schellens, J; Stewart, FA; Triesscheijn, M; Van Berkel, TJ | 1 |
| Andersson-Engels, S; Axelsson, J; Bendsoe, N; Gräfe, S; Johansson, A; Persson, L; Svanberg, K; Svanberg, S; Svensson, J; Trebst, T | 1 |
| Haase, T; Kahle, B; Kübler, AC; Mühling, J; Rheinwald, M; Staff, C | 1 |
| Gupta, G; MacKie, RM; Moore, JV; Morton, CA; Whitehurst, C | 1 |
| Morton, CA | 1 |
| Baas, P; Neering, H; Oppelaar, H; Saarnak, AE; Stewart, FA | 1 |
1 review(s) available for temoporfin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2015 |
4 trial(s) available for temoporfin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2008 |
The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Topics: Animals; Antineoplastic Agents; Apolipoproteins E; Area Under Curve; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Half-Life; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Mesoporphyrins; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasms; Photochemotherapy; Photosensitizing Agents; Scavenger Receptors, Class B; Species Specificity; Tissue Distribution | 2007 |
Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Laser Therapy; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prognosis; Prospective Studies; Radiation Dosage; Skin Neoplasms; Survival Rate; Treatment Outcome | 1999 |
Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Radiation Dosage; Skin Neoplasms; Treatment Outcome | 2001 |
6 other study(ies) available for temoporfin and Carcinoma, Basal Cell
| Article | Year |
|---|---|
Periorbital skin cancers subjected to mTHPC-photodynamic therapy: A prospective study.
Topics: Administration, Intravenous; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Male; Mesoporphyrins; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lasers, Semiconductor; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2012 |
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
Fluorescence monitoring of a topically applied liposomal Temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies.
Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorescence; Humans; Liposomes; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2007 |
Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Skin Neoplasms | 1999 |
Treating basal cell carcinoma: has photodynamic therapy come of age?
Topics: Carcinoma, Basal Cell; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2001 |